Francesca Citron

Aviano, 33081, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer.

DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer.

Journal: Cancer research

Published: August 26, 2025

RF-SIRF reveals a replication stress-specific epigenetic code by spatio-temporal mapping of reversed forks.

RF-SIRF reveals a replication stress-specific epigenetic code by spatio-temporal mapping of reversed forks.

Journal: Nature communications

Published: April 16, 2025

GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma.

GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma.

Journal: Cancer research

Published: November 06, 2024

WRAD core perturbation impairs DNA replication fidelity promoting immunoediting in pancreatic cancer.

WRAD core perturbation impairs DNA replication fidelity promoting immunoediting in pancreatic cancer.

Journal: bioRxiv : the preprint server for biology

Published: November 01, 2024

miR-1297 is frequently downmodulated in flat epithelial atypia of the breast and promotes mammary neoplastic transformation via EphrinA2 regulation.

miR-1297 is frequently downmodulated in flat epithelial atypia of the breast and promotes mammary neoplastic transformation via EphrinA2 regulation.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 31, 2024

Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers.

Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers.

Journal: Cell reports. Medicine

Published: September 02, 2024

Therapeutic targeting of Syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers.

Therapeutic targeting of Syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers.

Journal: bioRxiv : the preprint server for biology

Published: August 30, 2024

Activation of endogenous retroviruses and induction of viral mimicry by MEK1/2 inhibition in pancreatic cancer.

Activation of endogenous retroviruses and induction of viral mimicry by MEK1/2 inhibition in pancreatic cancer.

Journal: Science advances

Published: March 27, 2024

Clonal dominance defines metastatic dissemination in pancreatic cancer.

Clonal dominance defines metastatic dissemination in pancreatic cancer.

Journal: Science advances

Published: March 13, 2024

Evolutionary fingerprints of EMT in pancreatic cancers.

Evolutionary fingerprints of EMT in pancreatic cancers.

Journal: bioRxiv : the preprint server for biology

Published: October 03, 2023

Evolutionary fingerprints of epithelial-to-mesenchymal transition.

Evolutionary fingerprints of epithelial-to-mesenchymal transition.

Journal: Nature

Published: July 11, 2023

Loss of CDKN1B induces an age-related clonal hematopoietic disorder via Notch2 activity dysregulation.

Loss of CDKN1B induces an age-related clonal hematopoietic disorder via Notch2 activity dysregulation.

Journal: Cancer communications (London, England)

Published: December 12, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026